Scholar Rock Holding (FRA:2QK) Buyback Yield %: -1.52 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2QK Scholar Rock Holding Corp FRA:2QK
30 GF Score
Price €47.66
! 5 Warning Signs
View Full Analysis

What is Scholar Rock Holding Buyback Yield %?

Scholar Rock Holding FRA:2QK -3.21% 30 Buyback Yield % is -1.52 as of Jul. 15, 2026. GuruFocus rates FRA:2QK with a GF Score™ of 30/100. The stock has 5 warning signs investors should review. Among 741 Biotechnology companies, Scholar Rock Holding ranks better than 70.45% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Scholar Rock Holding's current buyback yield was -1.52%.

Scholar Rock Holding Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Scholar Rock Holding's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scholar Rock Holding Buyback Yield % Chart

Scholar Rock Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.48 -47.89 -6.44 -7.82 -1.90

Scholar Rock Holding Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.92 -1.67

FRA:2QK vs COGT, CGON, PTCT: Buyback Yield % Comparison

For the Biotechnology subindustry, Scholar Rock Holding's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scholar Rock Holding Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scholar Rock Holding's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Scholar Rock Holding's Buyback Yield % falls into.


FRA:2QK
30GF Score
Scholar Rock Holding Corp FRA:2QK
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scholar Rock Holding Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Scholar Rock Holding's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 78.278) / 4121.518
=-1.90%

Scholar Rock Holding's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 84.77) / 4478.3104
=-1.89%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -1.52 mean?
Scholar Rock Holding (FRA:2QK) has a Buyback Yield % of -1.52 as of Jul. 15, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Scholar Rock Holding and its competitors. According to the industry distribution chart, Scholar Rock Holding ranks #219 out of 741 companies in the Biotechnology industry, placing it in the top 29.6%.
Is Scholar Rock Holding's Buyback Yield % too high?
Scholar Rock Holding's current Buyback Yield % is -1.52. Based on the distribution chart, Scholar Rock Holding ranks #219 out of 741 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Scholar Rock Holding has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Scholar Rock Holding's Buyback Yield % compare to COGT and CGON?
According to the Biotechnology industry distribution chart, Scholar Rock Holding ranks #219 out of 741 companies for Buyback Yield %. This puts Scholar Rock Holding in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Scholar Rock Holding and its competitors. Scholar Rock Holding's current Buyback Yield % is -1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scholar Rock Holding stock overvalued right now?
Scholar Rock Holding (FRA:2QK) has a current Buyback Yield % of -1.52. The current Buyback Yield % is -1.52. Scholar Rock Holding's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Scholar Rock Holding (FRA:2QK), the current Buyback Yield % is -1.52 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scholar Rock Holding Business Description

Other Exchanges SRRK:USA2QK:Germany
Address 301 Binney Street, 3rd Floor, Cambridge, MA, USA, 02142
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
30GF Score

Get the complete analysis for FRA:2QK

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€47.66
Price